Annette M. Lim

PD-1 Blockade with Cemiplimab in Advanced Cutaneous Squamous-Cell Carcinoma

Michael R. Migden, Danny Rischin, Chrysalyne D. Schmults et al. · New England Journal of Medicine · 2018 · 1.3K citations · Full text

Neoadjuvant Cemiplimab for Stage II to IV Cutaneous Squamous-Cell Carcinoma

Neil D. Gross, David M. Miller, Nikhil I. Khushalani et al. · New England Journal of Medicine · 2022 · 288 citations · Full text

Phase 2 study of cemiplimab in patients with metastatic cutaneous squamous cell carcinoma: primary analysis of fixed-dosing, long-term outcome of weight-based dosing

Danny Rischin, Michael R. Migden, Annette M. Lim et al. · Journal for ImmunoTherapy of Cancer · 2020 · 169 citations · Full text

Integrated analysis of a phase 2 study of cemiplimab in advanced cutaneous squamous cell carcinoma: extended follow-up of outcomes and quality of life analysis

Danny Rischin, Nikhil I. Khushalani, Chrysalyne D. Schmults et al. · Journal for ImmunoTherapy of Cancer · 2021 · 101 citations · Full text

Cancer Management, Median Time, Dermatology +16

Relationship between Epidermal Growth Factor Receptor Status, p16INK4A, and Outcome in Head and Neck Squamous Cell Carcinoma

Richard J. Young, Danny Rischin, Richard Fisher et al. · Cancer Epidemiology Biomarkers & Prevention · 2011 · 91 citations